DETERMINATION
On the basis of the record(1) developed in the subject five-year review, the United States International Trade Commission determines, pursuant to section 751(c) of the Tariff Act of 1930 (19 U.S.C. § 1675(c)) (the Act), that revocation of the antidumping duty order on aspirin from Turkey would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time.(2)
BACKGROUND
The Commission instituted this review on March 1, 1999 (64 F.R. 10012) and determined on June 3, 1999, that it would conduct an expedited review (64 F.R. 31608).
The Commission transmitted its determination in this investigation to the Secretary of Commerce on July 29, 1999. The views of the Commission are contained in USITC Publication 3215 (July 1999), entitled Aspirin from Turkey: Investigation No. 731-TA-364 (Review).
By order of the Commission.
Donna R.
Koehnke
Secretary
Issued: July 30, 1999
1. The record is defined in sec. 207.2(f) of the Commission's Rules of Practice and Procedure (19 CFR § 207.2(f)).
2. Commissioners Carol T. Crawford and Thelma J. Askey dissenting, determining that revocation of the antidumping duty order would not be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time.